S2 Genomics Announces Distribution Agreement with Techtum Lab AB
Singulator™ 100 System and components to be available through local distributor in Norway, Finland, Denmark and Sweden. S2 Genomics, Inc. today announced that it has...
Tag : genomic testing
Precision BioSciences Announces Senior Leadership Changes
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced promotions and organizational...
Armonica Technologies Awarded NIH Grant
Armonica Technologies, Inc., a biotechnology company developing a novel DNA sequencing system based on single molecule spectroscopy, announced that the company has been awarded a...
Sectra extends medical diagnostics business to include genomics IT
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) is initiating a new business unit to drive innovation and product development within the area of...
OpGen Launches Ares Sequencing Services in the U.S.
Expanding services and offerings to the infectious disease community throughout the U.S. provides revenue growth opportunity Services at launch include rapid turnaround sequencing of clinical...
AncestryDNA® Expands to 54 New Markets Globally
Ancestry®, the global leader in family history and consumer genomics, today announced it has expanded AncestryDNA® to 54 new markets across North America, South America,...
Illumina Genomics Forum to Feature Anne Wojcicki
Session will focus on disrupting the status quo by empowering consumers to make more proactive, informed health care decisions Illumina, Inc. (NASDAQ: ILMN), a global leader...
Congenica Announces Partnership With Avesthagen
New deal strengthens Congenica’s presence in India Congenica, a digital health company that enables precision medicine through its world-leading diagnostic decision support platform for genomic...
Proteintech Group establishes a new subsidiary Proteintech Genomics
Proteintech Group today announces that it has established a new subsidiary company, Proteintech Genomics, based out of the thriving life sciences hub of San Diego,...
10x Genomics Reports Second Quarter 2022 Financial Results
10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the second quarter ended June 30, 2022. Recent Highlights Revenue was $114.6 million for the second quarter, representing a...